Skip to content

NeMus 2 System

by EB Neuro S.p.A.

510(k) K133517

Active European Union and United States

CE MDR 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, FDA 510(k), synced 6 Oct 2026.

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE 510(k) Substantially Equivalent · Traditional NumberK133517 Date26 Feb 2014ClearedStatusActive
European UnionCE/MDR EUDAMED Number— Date—StatusActive

Official records

From the FDA record

Received by the FDA
15 Nov 2013
FDA decision
26 Feb 2014 (Substantially Equivalent)
FDA review time
103 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K133517 (openFDA), as read on 6 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Across registries

2 registries list this device

  • FDA 510(k) K133517 decided 26 Feb 2014 Active
  • EUDAMED Active

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/MDR Active
  • United States FDA 510(k) Active

Specification

EUDAMED · 510(k)

510(k) Number
FDA product code
GWL
Device class
Class II
Regulation
21 CFR Part 882.1835
Advisory committee
Neurology
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The NeMus 2 System is a physiological signal amplifier designed for neurophysiological monitoring and diagnostic purposes, including electroencephalography (EEG) and somatosensory evoked potentials (SEP). It is classified as a Class II medical device under FDA regulations, intended for recording and analyzing neural signals in clinical settings.

This system is supplied as a reusable, multi-channel amplifier with expandable features, intended for use in intensive care units (ICU) and neurophysiological laboratories. It is regulated under FDA 510(k) clearance and the EU Medical Device Regulation (MDR), with specific compliance to regulation number 882.1835. The device supports various monitoring applications, including EEG and SEP with alternating bilateral stimulation, and is intended for use by trained personnel in clinical environments.

Devices cleared under K133517

5 devices · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K133517
UDI-DISize and differences
NeMus 2 + B9800066801
EB NEURO SPA
B980006680108056446900352 —On the market
NeMus 2 600 B9800066601
EB NEURO SPA
B980006660108056446900338 —On the market
NeMus 2 700 B9800066701
EB NEURO SPA
B980006670108056446900345 —On the market
NeMus 2 B9700066010
EB NEURO SPA
B970006601008056446900376 —On the market
NeMus 2 B9800066010
EB NEURO SPA
B980006601008056446900369 —On the market

Similar devices

Other devices filed under FDA product code GWL (Amplifier, Physiological Signal).

Other devices from EB Neuro S.p.A.

See all devices from EB Neuro S.p.A. →